Id: acc1952
Group: 2sens
Protein: IRS-1
Gene Symbol: IRS1
Protein Id: P35568
Protein Name: IRS1_HUMAN
PTM: phosphorylation
Site: Tyr
Site Sequence:
Disease Category: Cancer
Disease: Hepatocellular Carcinoma
Disease Subtype:
Disease Cellline: FOCUS
Disease Info:
Drug: ethanol
Drug Info: -
Effect: modulate
Effect Info: Drug treatment inhibits protein phosphorylation.
Note: "no tumor effct, site unclear"
Score: 3.0
Pubmed(PMID): 9884156
Sentence Index:
Sentence:

Sequence & Structure:

MASPPESDGFSDVRKVGYLRKPKSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESCFNINKRADSKNKHLVALYTRDEHFAIAADSEAEQDSWYQALLQLHNRAKGHHDGAAALGAGGGGGSCSGSSGLGEAGEDLSYGDVPPGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGEFWMQVDDSVVAQNMHETILEAMRAMSDEFRPRSKSQSSSNCSNPISVPLRRHHLNNPPPSQVGLTRRSRTESITATSPASMVGGKPGSFRVRASSDGEGTMSRPASVDGSPVSPSTNRTHAHRHRGSARLHPPLNHSRSIPMPASRCSPSATSPVSLSSSSTSGHGSTSDCLFPRRSSASVSGSPSDGGFISSDEYGSSPCDFRSSFRSVTPDSLGHTPPARGEEELSNYICMGGKGPSTLTAPNGHYILSRGGNGHRCTPGTGLGTSPALAGDEAASAADLDNRFRKRTHSAGTSPTITHQKTPSQSSVASIEEYTEMMPAYPPGGGSGGRLPGHRHSAFVPTRSYPEEGLEMHPLERRGGHHRPDSSTLHTDDGYMPMSPGVAPVPSGRKGSGDYMPMSPKSVSAPQQIINPIRRHPQRVDPNGYMMMSPSGGCSPDIGGGPSSSSSSSNAVPSGTSYGKLWTNGVGGHHSHVLPHPKPPVESSGGKLLPCTGDYMNMSPVGDSNTSSPSDCYYGPEDPQHKPVLSYYSLPRSFKHTQRPGEPEEGARHQHLRLSTSSGRLLYAATADDSSSSTSSDSLGGGYCGARLEPSLPHPHHQVLQPHLPRKVDTAAQTNSRLARPTRLSLGDPKASTLPRAREQQQQQQPLLHPPEPKSPGEYVNIEFGSDQSGYLSGPVAFHSSPSVRCPSQLQPAPREEETGTEEYMKMDLGPGRRAAWQESTGVEMGRLGPAPPGAASICRPTRAVPSSRGDYMTMQMSCPRQSYVDTSPAAPVSYADMRTGIAAEEVSLPRATMAAASSSSAASASPTGPQGAAELAAHSSLLGGPQGPGGMSAFTRVNLSPNRNQSAKVIRADPQGCRRRHSSETFSSTPSATRVGNTVPFGAGAAVGGGGGSSSSSEDVKRHSSASFENVWLRPGELGGAPKEPAKLCGAAGGLENGLNYIDLDLVKDFKQCPQECTPEPQPPPPPPPHQPLGSGESSSTRRSSEDLSAYASISFQKQPEDRQ

Select PDB:

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets
Small molecule
Antibody
PROTAC
Other modalities
Approved Drug
Advanced Clinical
Phase 1 Clinical
Structure with Ligand
High-Quality Ligand
High-Quality Pocket
Med-Quality Pocket
Druggable Family
Approved Drug
Advanced Clinical
Phase 1 Clinical
UniProt loc high conf
GO CC high conf
UniProt loc med conf
UniProt SigP or TMHMM
GO CC med conf
Human Protein Atlas loc
Approved Drug
Advanced Clinical
Phase 1 Clinical
Literature
UniProt Ubiquitination
Database Ubiquitination
Half-life Data
Small Molecule Binder
Approved Drug
Advanced Clinical
Phase 1 Clinical

PTM Intensity:

source: CPTAC

No intensity data of this site,
show all other sites!

IRS1-Ser1078
Cancer Intensity
BRCA 0.802
COAD -0.081
HGSC
ccRCC 1.069
GBM
HNSC -0.588
LUAD -0.718
LUSC -1.527
non_ccRCC -0.92
PDAC 0.633
UCEC 1.329
IRS1-Ser1100
Cancer Intensity
BRCA -1.198
COAD 0.679
HGSC -1.036
ccRCC
GBM
HNSC 1.268
LUAD 0.556
LUSC 1.082
non_ccRCC
PDAC -0.795
UCEC -0.556
IRS1-Ser1101
Cancer Intensity
BRCA -1.279
COAD 0.625
HGSC 1.291
ccRCC
GBM
HNSC 0.786
LUAD 0.106
LUSC 0.608
non_ccRCC
PDAC -1.182
UCEC -0.955
IRS1-Ser1109
Cancer Intensity
BRCA
COAD 0.707
HGSC -0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser1135
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser1142
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC -0.707
non_ccRCC
PDAC 0.707
UCEC
IRS1-Ser270
Cancer Intensity
BRCA 1.766
COAD -0.143
HGSC 1.365
ccRCC -0.451
GBM -0.761
HNSC -0.219
LUAD 0.149
LUSC 0.407
non_ccRCC 0.42
PDAC -1.81
UCEC -0.724
IRS1-Ser272
Cancer Intensity
BRCA
COAD -1.052
HGSC 0.938
ccRCC
GBM
HNSC
LUAD 0.114
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser273
Cancer Intensity
BRCA
COAD
HGSC -0.707
ccRCC
GBM
HNSC
LUAD 0.707
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser277
Cancer Intensity
BRCA -0.707
COAD
HGSC
ccRCC
GBM
HNSC 0.707
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser307
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC 1.155
LUAD -0.57
LUSC
non_ccRCC
PDAC
UCEC -0.585
IRS1-Ser315
Cancer Intensity
BRCA
COAD 0.703
HGSC 1.578
ccRCC -0.025
GBM
HNSC -1.037
LUAD -0.298
LUSC
non_ccRCC
PDAC
UCEC -0.922
IRS1-Ser323
Cancer Intensity
BRCA -1.325
COAD -0.062
HGSC 1.91
ccRCC -0.063
GBM -0.274
HNSC -0.33
LUAD -0.103
LUSC 0.454
non_ccRCC 1.383
PDAC -0.084
UCEC -1.506
IRS1-Ser330
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser337
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser341
Cancer Intensity
BRCA -0.79
COAD -0.134
HGSC 1.37
ccRCC
GBM
HNSC 0.694
LUAD 0.729
LUSC -0.335
non_ccRCC
PDAC
UCEC -1.535
IRS1-Ser345
Cancer Intensity
BRCA
COAD
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC -0.707
IRS1-Ser348
Cancer Intensity
BRCA
COAD 0.8
HGSC -1.121
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC 0.321
IRS1-Ser350
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser374
Cancer Intensity
BRCA
COAD 0.565
HGSC 1.187
ccRCC -0.149
GBM -0.371
HNSC -1.268
LUAD -0.049
LUSC
non_ccRCC
PDAC 1.365
UCEC -1.279
IRS1-Ser415
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC
LUAD 0.707
LUSC
non_ccRCC
PDAC
UCEC -0.707
IRS1-Ser419
Cancer Intensity
BRCA
COAD
HGSC -1.115
ccRCC
GBM
HNSC
LUAD 0.818
LUSC
non_ccRCC
PDAC
UCEC 0.296
IRS1-Ser421
Cancer Intensity
BRCA
COAD 0.524
HGSC -1.494
ccRCC
GBM
HNSC
LUAD 0.589
LUSC
non_ccRCC
PDAC
UCEC 0.382
IRS1-Ser444
Cancer Intensity
BRCA
COAD
HGSC -0.707
ccRCC
GBM 0.707
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser449
Cancer Intensity
BRCA
COAD
HGSC 1.255
ccRCC
GBM
HNSC -0.142
LUAD 0.07
LUSC
non_ccRCC
PDAC
UCEC -1.183
IRS1-Ser463
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM -0.707
HNSC 0.707
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Ser527
Cancer Intensity
BRCA -0.349
COAD 0.195
HGSC 1.597
ccRCC -0.896
GBM -0.176
HNSC -1.431
LUAD -0.424
LUSC 1.766
non_ccRCC
PDAC 0.043
UCEC -0.324
IRS1-Ser531
Cancer Intensity
BRCA -2.281
COAD 0.378
HGSC 1.07
ccRCC -0.307
GBM 0.901
HNSC -0.537
LUAD 0.451
LUSC -0.647
non_ccRCC
PDAC 0.154
UCEC 0.819
IRS1-Ser574
Cancer Intensity
BRCA
COAD
HGSC 1.312
ccRCC
GBM
HNSC -1.122
LUAD -0.06
LUSC
non_ccRCC
PDAC
UCEC -0.13
IRS1-Ser629
Cancer Intensity
BRCA
COAD -0.049
HGSC 1.819
ccRCC -0.257
GBM -0.559
HNSC -0.813
LUAD -0.141
LUSC -0.142
non_ccRCC 1.506
PDAC 0.158
UCEC -1.522
IRS1-Ser636
Cancer Intensity
BRCA 0.864
COAD -0.478
HGSC -1.149
ccRCC
GBM 1.248
HNSC
LUAD
LUSC 0.421
non_ccRCC 0.982
PDAC -1.278
UCEC -0.61
IRS1-Ser862
Cancer Intensity
BRCA 1.113
COAD -0.289
HGSC
ccRCC
GBM
HNSC -0.824
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Thr446
Cancer Intensity
BRCA
COAD
HGSC 1.105
ccRCC
GBM -0.921
HNSC 0.584
LUAD
LUSC
non_ccRCC
PDAC
UCEC -0.768
IRS1-Thr453
Cancer Intensity
BRCA
COAD 0.424
HGSC -0.776
ccRCC
GBM 1.145
HNSC -1.021
LUAD -1.197
LUSC 1.167
non_ccRCC
PDAC
UCEC 0.258
IRS1-Thr525
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.92
GBM 1.423
HNSC -0.223
LUAD
LUSC
non_ccRCC
PDAC
UCEC -0.28
IRS1-Thr530
Cancer Intensity
BRCA -1.934
COAD 0.689
HGSC 1.779
ccRCC 0.009
GBM
HNSC -0.527
LUAD 0.268
LUSC -0.232
non_ccRCC
PDAC 0.301
UCEC -0.353
IRS1-Thr533
Cancer Intensity
BRCA 0.707
COAD -0.707
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
IRS1-Tyr632
Cancer Intensity
BRCA -0.573
COAD 0.295
HGSC 1.706
ccRCC 0.013
GBM -0.016
HNSC -0.073
LUAD 0.15
LUSC 0.575
non_ccRCC
PDAC
UCEC -2.077

PTM-Disease Association:

source: PTMD
Residue Position State Disease Class PMID
- - D Polycystic ovary syndrome Phosphorylation 15130378
- - D Primitive neuroectodermal tumor Phosphorylation 8746448
- - U Ductal carcinoma in situ Phosphorylation 23562473
- - U Hepatocellular carcinoma/hepatocarcinoma/hepatoma Phosphorylation 7542850

State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.

PTM-Drug Perturbation Response:

source: DecryptM
Protein Gene PTM Position Modified sequence Cell Drug pEC50 Regulation Experiment
P35568 IRS1 P Ser629;Tyr632 KGS(ph)GDY(ph)MPMSPK A549 Staursporin 7.6212 -
P35568 IRS1 P Tyr46;Tyr47 LEY(ph)Y(ph)ENEK ARH-77 Rituximab -4.1833 -

pEC50 Note: pEC50 is the negative logarithm of EC50 (half-maximal effective concentration, dosage unit Mol), calculated as pEC50 = -log10(EC50), which quantifies the potency of a drug or compound.

Function score:

source: funscoR

No data.

Cross Links: